Fig. 5

Upregulation of CCL2, CCL8 and CCL12 chemokines, specifically in Ltα−/− mTEClo, correlates with the upregulation of classical NF-κB subunits. a Gating strategy and flow cytometry profiles used to analyse total mTECs (CD45-Ep-CAM+BP-1loUEA-1+), mTEClo (CD45−Ep-CAM+BP-1loUEA-1+CD80lo) and mTEChi (CD45−Ep-CAM+BP-1loUEA-1+CD80hi) in WT and Ltα−/− mice. This gating strategy was used to sort and analyse mTECs in Figs. 3 and 5. The histogram shows numbers of mTEClo and mTEChi cells in both mice. b Ccl2, ccl8 and ccl12 mRNAs were measured by qPCR in purified mTEClo and mTEChi from WT (n = 8) and Ltα−/− (n = 8) mice. c, d MCP1–4 (c) and phosphorylation of Ser536 p65 (d) were analysed by flow cytometry in mTEClo from WT and Ltα−/− mice. Histograms show the MFI of MCP1–4 and phospho p65 (Ser536). e Relb, Rel and Rela mRNAs were measured by qPCR in purified mTEClo from WT (n = 8) and Ltα −/− (n = 8) mice. f, g RelB (f) and p65 (g) protein levels were analysed by flow cytometry in mTEClo from WT and Ltα−/− mice. Histograms show the MFI of RelB and p65 expression. h LTβR expression was analysed by flow cytometry in WT mTEClo. The histogram shows the MFI of LTβR. i Relb, Rel and Rela mRNAs were measured by qPCR in mTECs loaded (n = 6) or not (n = 6) with OVA323–339 peptide co-cultured with CD4+ thymocytes from OTII-Rag2−/− mice or OTII-Rag2−/−xLtα −/− mice. a–i Data are representative of two independent experiments (n = 3-4 mice per group and per experiment). II abs secondary antibodies, FMO fluorescence minus one, MFI mean fluorescence intensity. Error bars show mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 using one-tailed Mann–Whitney test for c, f, g, two-tailed Mann–Whitney test for h and unpaired Student’s t-test for b, e and i